Pneumopathie interstitielle granulomato-lymphocytaire dans l'immunodéficience commune variable [Granulomatous lymphocytic interstitial lung disease in common variable immunodeficiency].


Autoria(s): Bianchi M.P.; Letovanec I.; Spertini F.; Nicod L.P.; Lazor R.
Data(s)

2013

Resumo

Common variable immunodeficiency (CVID) is the most frequent primary immune deficiency. Recurrent infections are classical consequences of CVID, but their impact has been largely reduced by immunoglobulin replacement. CVID is also associated with various inflammatory and autoimmune manifestations resulting from abnormal cellular immunity. The lungs are especially affected by a recently described entity called granulomatous lymphocytic interstitial lung disease (GLILD). GLILD currently constitutes an important cause of morbidity and mortality in these patients. It is distinct from bronchiectasis secondary to recurrent infections, and presents similarities but also striking differences with sarcoidosis.

Identificador

http://serval.unil.ch/?id=serval:BIB_6BC47993F101

isbn:1660-9379 (Print)

pmid:24354253

Idioma(s)

fr

Fonte

Revue Médicale Suisse, vol. 9, no. 407, pp. 2175-2180

Palavras-Chave #Bronchiectasis/diagnosis; Bronchiectasis/physiopathology; Common Variable Immunodeficiency/diagnosis; Common Variable Immunodeficiency/physiopathology; Granuloma/diagnosis; Granuloma/pathology; Humans; Immunoglobulins/administration & dosage; Lung Diseases, Interstitial/diagnosis; Lung Diseases, Interstitial/physiopathology; Prognosis; Recurrence; Sarcoidosis/diagnosis; Sarcoidosis/physiopathology
Tipo

info:eu-repo/semantics/review

article